Home / Inspections / 1054739

FDA Inspection 1054739 — Hikma Pharmaceuticals USA, Inc.

Hikma Pharmaceuticals USA, Inc. — FEI 2250102

The FDA completed an inspection of Hikma Pharmaceuticals USA, Inc. on April 13, 2018 in Eatontown, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 13, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Eatontown, NJ (United States)

Facility

Other inspections at this facility

  • 1079961 (NAI Fri Feb 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 976090 (NAI Thu Jul 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 942928 (NAI Thu Sep 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 864847 (VAI Wed Feb 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 829253 (OAI Fri Jun 07 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources